LifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter

Enabling LifeArc Ventures to speak directly to fellow investors, life science companies and entrepreneurial scientists.

From donkeys to diversity – Anji Miller reports from AUTM 2023

Takeaways from AUTM's Annual Conference for the technology transfer sector

LifeArc responds to the Government’s Spring Budget

LifeArc CEO Dr Melanie Lee responds to today's Spring Budget.

International Women’s Day 2023

Tips on career advancement, from some of LifeArc’s incredible women

The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc

The Board at LifeArc announces today it is sponsoring five Daphne Jackson Fellowships.

Honouring the contribution of a remarkable trustee – Aisling Burnand CBE

Melanie Lee pays tribute to Aisling Burnand and her immense contribution to the life sciences sector.

Rare Disease Day 2023 – Robbie’s story

Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.

Four ways we support rare disease research

LifeArc provides a range of advice, funding and science to help scientists turn promising research into potential treatments.

LifeArc awards £3 million to advance promising early rare disease research from the lab to the patient

Pump-prime funding to help researchers get innovative approaches off the ground